Cassava Sciences Other Long Term Assets (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

1.99 -0.05 (-2.45%) USD | NASDAQ | Jan 20, 16:00

2.00 +0.01 (+0.50%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

cbdMD, Inc.	--
BioMarin Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade
Geron Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade